adex-10q_20210331.htm

0001564590-21-035566.txt : 20210702 0001564590-21-035566.hdr.sgml : 20210702 20210701202549 ACCESSION NUMBER: 0001564590-21-035566 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 46 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210702 DATE AS OF CHANGE: 20210701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adit EdTech Acquisition Corp. CENTRAL INDEX KEY: 0001830029 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 853477678 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39872 FILM NUMBER: 211067752 BUSINESS ADDRESS: STREET 1: 1345 AVENUE OF THE AMERICAS STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10105 BUSINESS PHONE: (917) 392-4707 MAIL ADDRESS: STREET 1: 1345 AVENUE OF THE AMERICAS STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10105 10-Q 1 adex-10q_20210331.htm 10-Q adex-10q_20210331.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-39872

ADIT EDTECH ACQUISITION CORP.

(Exact Name of Registrant as Specified in its Charter)

Delaware

85-3477678

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1345 Avenue of the Americas, 33rd Floor

New York, New York

(Address of principal executive offices, including zip code)

(646) 291-6930

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of common stock and one-half of one redeemable warrant	ADEX.U	New York Stock Exchange
Common Stock, par value $0.0001 per share	ADEX	New York Stock Exchange
Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share	ADEX.WS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act

Large accelerated filer	☐	Accelerated filer	☐

Non-accelerated Filer	☒	Smaller reporting company	☒

		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of June 30, 2021, there were 34,500,000 outstanding shares of the registrant’s common stock, $0.0001 par value per share.

ADIT EDTECH ACQUISITION CORP.

Quarterly Report on Form 10-Q

Table of Contents

PART I. FINANCIAL INFORMATION		1

Item 1.	Financial Statements	1

	Condensed Balance Sheets as of March 31, 2021 (unaudited) and December 31, 2020	1

	Unaudited Condensed Statement of Operations for the three months ended March 31, 2021	2

	Unaudited Condensed Statement of Changes in Stockholders’ Equity for the three months ended March 31, 2021	3

	Unaudited Condensed Statement of Cash Flows for the three months ended March 31, 2021	4

	Notes to Unaudited Condensed Financial Statements	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	20

Item 4.	Controls and Procedures	20

PART II. OTHER INFORMATION		21

Item 1.	Legal Proceedings	21

Item 1A.	Risk Factors	21

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	21

Item 3.	Defaults Upon Senior Securities	22

Item 4.	Mine Safety Disclosures	22

Item 5.	Other Information	22

Item 6.	Exhibits	23

SIGNATURES		24

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

ADIT EDTECH ACQUISITION CORP.

CONDENSED BALANCE SHEETS

	March 31, 2021			December 31, 2020
	(unaudited)
Assets
Current asset - Cash	$	729,607		$	35,614
Prepaid expenses		292,500			—
Deferred offering costs		—			469,160
Total current assets		1,022,107			504,774
Prepaid expenses, non-current		206,404			—
Cash and securities held in Trust Account		276,040,259			—
Total Assets	$	277,268,770		$	504,774
Liabilities and Stockholders’ Equity
Current liabilities:
Accrued offering costs and expenses	$	11,350		$	330,300
Due to related party		18,986			—
Promissory note - related party		150,000			150,000
Total current liabilities		180,336			480,300
Deferred underwriting discount		9,660,000			—
Total liabilities		9,840,336			480,300
Commitments
Common Stock subject to possible redemption, 26,242,843 and 0 shares at redemption value, respectively		262,428,430			—
Stockholders’ Equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—			—
Common stock, $0.0001 par value; 100,000,000 shares authorized; 8,257,157 and 6,900,000 shares issued and outstanding (excluding 26,242,843 and 0 shares subject to possible redemption, respectively)		826			690
Additional paid-in capital		5,049,658			24,310
Accumulated deficit		(50,480	)		(526	)
Total Stockholders’ equity		5,000,004			24,474
Total Liabilities and Stockholders’ Equity	$	277,268,770		$	504,774

The accompanying notes are an integral part of these unaudited condensed financial statements.

ADIT EDTECH ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF OPERATIONS

	For the Three Months Ended March 31, 2021
Formation and operating costs	$	90,213
Loss from operations		(90,213	)
Other income
Trust interest income		40,259
Total other income		40,259
Net loss	$	(49,954	)
Basic and diluted weighted average shares outstanding, common stock subject to redemption		19,231,241
Basic and diluted net income per share	$	—
Basic and diluted weighted average shares outstanding, common stock		13,815,426
Basic and diluted net loss per share	$	(0.00	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

ADIT EDTECH ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

	Common Stock						Additional			Retained			Total Stockholders'
	Shares			Amount			Paid-in Capital			Earnings			Equity
Balance as of December 31, 2020		6,900,000		$	690		$	24,310		$	(526	)	$	24,474
Sale of 27,600,000 Units, net of underwriting discount and offering expenses		27,600,000			2,760			267,451,154			—			267,453,914
Net loss		—			—			—			(49,954	)		(49,954	)
Change in common stock subject to possible redemption		(26,242,843	)		(2,624	)		(262,425,806	)		—			(262,428,430	)
Balance as of March 31, 2021		8,257,157		$	826		$	5,049,658		$	(50,480	)	$	5,000,004

The accompanying notes are an integral part of these unaudited condensed financial statements.

ADIT EDTECH ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS

	For the three months ended March 31, 2021
Cash flows from Operating Activities:
Net loss	$	(49,954	)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on cash and marketable securities held in Trust Account		(40,259	)
Changes in current assets and current liabilities:
Prepaid expenses		(498,904	)
Accrued offering costs and expenses		168,983
Due to related party		213
Net cash used in operating activities		(419,921	)
Cash Flows from Investing Activities:
Investment held in Trust Account		(276,000,000	)
Net cash used in investing activities		(276,000,000	)
Cash flows from Financing Activities:
Proceeds from Initial Public Offering, net of underwriters’ fees		270,480,000
Proceeds from private placement		7,270,000
Payments of offering costs		(636,086	)
Net cash provided by financing activities		277,113,914
Net change in cash		693,993
Cash, beginning of the period		35,614
Cash, end of the period	$	729,607
Supplemental disclosure of noncash investing and financing activities:
Deferred underwriting commissions charged to additional paid in capital	$	9,660,000
Initial value of common stock subject to possible redemption	$	227,738,380
Change in value of common stock subject to possible redemption	$	34,690,050
Deferred offering costs paid by Sponsor loan	$	18,773

The accompanying notes are an integral part of these unaudited condensed financial statements.

ADIT EDTECH ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 1 — Organization and Business Operations

Organization and General

Adit EdTech Acquisition Corp. (the “Company”) was incorporated in Delaware on October 15, 2020. The Company is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus its search for a business that would benefit from its founders’ and management team’s experience and ability to identify, acquire and manage a business in the education, training and education technology industries.

The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

The Company has selected December 31 as its fiscal year end.

As of March 31, 2021, the Company had not commenced any operations. All activity for the period from October 15, 2020 (inception) through March 31, 2021 relates to the Company’s formation and the initial public offering (“IPO”), which is described below, and since the closing of the IPO, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO.

The Company’s sponsor is Adit EdTech Sponsor, LLC, a Delaware limited liability company (the “Sponsor”).

Financing

The registration statements for the Company’s IPO were declared effective on January 11, 2021 (the “Effective Date”). On January 14, 2021, the Company consummated the IPO of 24,000,000 units (the “Units” and, with respect to the shares of common stock included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $240,000,000.

Simultaneously with the closing of the IPO, the Company consummated the sale of 6,550,000 Private Placement Warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor, generating total gross proceeds of $6,550,000.

Transaction costs amounted to $13,836,086 consisting of $4,800,000 of underwriting discount, $8,400,000 deferred underwriting discount, and $636,086 of other offering costs.

The Company granted the underwriters in the IPO a 45-day option to purchase up to 3,600,000 additional Units to cover over-allotments, if any. On January 19, 2021, the underwriters exercised the over-allotment option in full to purchase 3,600,000 Units (the “Over-allotment Units”), generating aggregate gross proceeds of $36,000,000, and incurred $720,000 in deferred underwriting fees. Simultaneously with the closing of the sale of the Over-allotment Units, the Company consummated the sale of an additional 720,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $720,000.

Trust Account

Following the closing of the IPO on January 14, 2021 and the underwriters’ full exercise of over-allotment option on January 19,2021, $276,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO, the sale of Over-allotment Units and the sale of the Private Placement Warrants was placed in a Trust Account, which are held as cash or invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account.

Initial Business Combination

The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption will be recorded at redemption value and classified as temporary equity upon the completion of the IPO in accordance with the Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the then outstanding shares of common stock present and entitled to vote at the meeting to approve the Business Combination are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the IPO in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.

Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

The Sponsor and the Company’s officers, directors and industry advisors have agreed (a) to waive redemption rights with respect to the Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination and certain amendments to the Amended and Restated Certificate of Incorporation or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

The Company will have until January 14, 2023 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period and stockholders do not approve an amendment to the Amended and Restated Certificate of Incorporation to extend this date, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

The holders of the Founder Shares have agreed to waive liquidation rights with respect to such shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the IPO, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00).

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay the Company’s tax obligation and up to $100,000 for liquidation excepts, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account (even if such waiver is deemed to be unenforceable) and except as to any claims under the Company’s indemnity of the underwriters of IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Liquidity and Capital Resources

As of March 31, 2021, the Company had approximately $0.7 million in its operating bank account, and working capital of approximately $0.8 million.

Prior to the completion of the IPO, the Company’s liquidity needs had been satisfied through a payment from the Sponsor of $25,000 (see Note 5) for the Founder Shares to cover certain offering costs, the loan under an unsecured promissory note from the Sponsor of $150,000 (see Note 5), and the net proceeds from the consummation of the Private Placement not held in the Trust Account. Subsequent to the consummation of the IPO and sale of Private Placement Warrants, the Company’s liquidity needs have been satisfied through the proceeds from the consummation of the sale of Private Placement Warrants not held in the Trust Account.

In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or the Company’s officers and directors or their affiliates may, but are not obligated to, provide the Company Working Capital Loans (as defined below) (see Note 5). To date, there were no amounts outstanding under any Working Capital Loans.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on January 21, 2021 and January 13, 2021, respectively.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statement.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2021 and December 31, 2020.

Investment Held in Trust Account

Investment held in Trust Account consist of United States Treasury securities. The Company classifies its United States Treasury securities as held-to-maturity in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts.

A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the

reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry the investee operates in.

Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion is included in the “Trust interest income” line item in the statements of operations. Trust interest income is recognized when earned.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

•

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet. The fair values of cash and cash equivalents, prepaid expenses, accrued offering costs and expenses, due to related party, and promissory note to related party are estimated to approximate the carrying values as of March 31, 2021 due to the short maturities of such instruments.

The following tables present information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2021, and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.

	March 31,		Quoted Prices In Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2021		(Level 1)		(Level 2)		(Level 3)
Assets:
U.S. Money Market held in Trust Account	$	809	$	809	$	—	$	—
U.S. Treasury Securities		276,039,450		276,039,450		—		—
	$	276,040,259	$	276,040,259	$	—	$	—

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At March 31, 2021 and December 31, 2020, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock feature certain redemption rights that is considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.

Net Income (Loss) Per Common Share

Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common share outstanding for each of the periods. The warrants are exercisable to purchase 21,070,000 shares of common stock in the aggregate.

The Company’s statement of operations includes a presentation of income (loss) per share for common share subject to possible redemption in a manner similar to the two-class method of income (loss) per common share. Net income per common share, basic and diluted, for redeemable common share is calculated by dividing the interest income earned on the Trust Account, by the weighted average number of redeemable common share outstanding since original issuance. Net loss per common share, basic and diluted, for non-redeemable common share is calculated by dividing the net loss, adjusted for income attributable to redeemable common share, by the weighted average number of non-redeemable common share outstanding for the periods. Non-redeemable common share includes the founder shares as these common shares do not have any redemption features and do not participate in the income earned on the Trust Account.

	For the Three Months Ended March 31, 2021
Common stock subject to possible redemption
Numerator: net income allocable to common stock subject to possible redemption
Amortized interest income on marketable securities held in trust	$	38,278
Less: interest available to be withdrawn for payment of taxes		(38,278	)
Net income allocable to common stock subject to possible redemption	$	—
Denominator: weighted average redeemable common stock redeemable common stock, basic and diluted		19,231,241
Basic and diluted net income per share, redeemable common stock	$	—
Non-redeemable common stock
Numerator: net loss minus redeemable net earnings
Net loss	$	(49,954	)
Redeemable net earnings		—
Non-redeemable net loss	$	(49,954	)
Denominator: weighted average non-redeemable basic and diluted weighted average shares outstanding, common stock		13,815,426
Basic and diluted net loss per share, common stock	$	(0.00	)

Offering Costs associated with the Initial Public Offering

date that are related to the IPO and were charged to stockholders’ equity upon the completion of the IPO. Accordingly, on January 14, 2021, offering costs in the aggregate of $13,836,086 have been charged to stockholders’ equity (consisting of $4,800,000 of underwriting discount, $8,400,000 of deferred underwriting discount, and $636,086 of other offering costs).

Derivative Financial Instruments

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Stock (“ASC 815-40”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

The Company has evaluated both the public and private warrants under ASC 480 and ASC 815-40 and has concluded that it is properly classified as equity instruments.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the unaudited condensed financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the unaudited condensed financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic on the Company’s financial statements and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statement.

Note 3 — Initial Public Offering

Pursuant to the IPO on January 14, 2021, the Company sold 24,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of common stock and one half of one warrant to purchase one share of common stock (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment.

On January 14, 2021, an aggregate of $10.00 per Unit sold in the IPO was held in the Trust Account and will be held as cash or invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act.

On January 19, 2021, the Underwriters exercised the over-allotment option in full to purchase 3,600,000 Units.

Following the closing of the IPO on January 14, 2021 and the underwriters’ full exercise of over-allotment option on January 19, 2021, $276,000,000 was held in the Trust Account.

Note 4 — Private Placement

Simultaneously with the closing of the IPO on January 14, 2021, the Sponsor purchased an aggregate of 6,550,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $6,550,000, in a private placement (the “Private Placement”).

On January 19, 2021, the Underwriters exercised the over-allotment option in full to purchase 3,600,000 Units. Simultaneously with the closing of the exercise of the overallotment option, the Company completed the private sale of an aggregate of 720,000 Private Placement Warrants to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds of $720,000.

Each Private Placement Warrant will entitle the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment. The proceeds from the Private Placement Warrants was added to the proceeds from the IPO held in the Trust Account on January 14, 2021. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

Note 5 — Related Party Transactions

Founder Shares

In October 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration of 5,750,000 shares of the Company’s common stock (the “Founder Shares”). On October 27, 2020, the Sponsor transferred 10,000 Founder Shares to each of the Company’s independent directors and 7,500 Founder Shares to each of the Company’s industry advisors at their original purchase price (the Sponsor, independent directors and industry advisors being defined herein collectively as the “initial stockholders”). On January 11, 2021, the Company effected a stock dividend of 1,150,000 shares with respect to the common stock, resulting in the initial stockholders holding an aggregate of 6,900,000 Founder Shares (up to 900,000 of which are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised). As such, the initial stockholders collectively own 20% of the Company’s issued and outstanding shares of common stock after the IPO. On January 19, 2021, the underwriter exercised its over-allotment option in full, hence, the 900,000 Founder Shares are no longer subject to forfeiture since then.

The initial stockholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Due to Related Parties

As of March 31, 2021, one related party paid an aggregate of $18,986 on behalf of the Company to pay for offering and operating costs.

Promissory Note — Related Party

On October 23, 2020 the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $150,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) June 30, 2021, (ii) the consummation of the IPO, (iii) the abandonment of the IPO and (iv) an Event of Default as defined in the Promissory Note. As of March 31, 2021 and December 31, 2020, the Company had borrowed $150,000 under the Promissory Note.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Initial Stockholder, the Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $2,000,000 of the notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of March 31, 2021 and December 31, 2020, no such Working Capital Loans were outstanding.

Administrative Service Fee

The Company entered into an agreement whereby, commencing on January 11, 2021, the Company has agreed to pay the Sponsor or an affiliate of the Sponsor an amount up to a total of $10,000 per month for office space, utilities, secretarial support and administrative services. Upon completion of the initial Business Combination or liquidation, the Company will cease paying these monthly fees.

Note 6 — Cash and Securities Held in Trust Account

As of March 31, 2021, investment in the Company’s Trust Account consisted of $809, in U.S. Money Market and $276,039,450, in U.S. Treasury Securities. The Company classifies its United States Treasury securities as held-to-maturity in accordance with FASB ASC 320 “Investments — Debt and Equity Securities”. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts. The Company considers all investments with original maturities of more than three months but less than one year to be short-term investments. The carrying value approximates the fair value due to its short-term maturity.

The carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities on March 31, 2021 are as follows:

	Carrying Value/Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value as of March 31, 2021
U.S. Money Market	$	809	$	—	$	—	$	809
U.S. Treasury Securities		276,039,450		—		5,789		276,045,240
	$	276,040,259	$	—	$	5,789	$	276,046,049

Note 7 — Commitments and Contingencies

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement signed on January 11, 2021, requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters have a 45-day option beginning January 14, 2021 to purchase up to an additional 3,600,000 units to cover over-allotments, if any, at the IPO price less the underwriting discounts.

On January 19, 2021, the underwriters purchased an additional 3,600,000 units to exercise its over-allotment option in full. The proceeds of $36,000,000 from the over-allotment was deposited in the Trust Account after deducting the underwriting discounts.

The underwriters were paid a cash underwriting discount of 2.0% of the gross proceeds of the IPO, or $5,520,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of 3.5% of the gross proceeds of the IPO, or $8,400,000 (or up to $9,660,000 if the underwriters’ over-allotment is exercised in full).

Note 8 — Stockholders’ Equity

Preferred Stock— The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding.

Common Stock— The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. As of March 31, 2021 and December 31, 2020, there were 8,257,157 and 6,900,000 shares of common stock issued and outstanding, excluding 26,242,843 and 0 shares of common stock subject to possible redemption.

Public Warrants— Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue any shares of common stock upon exercise of a warrant unless common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.

If the Company’s common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to maintain in effect a registration statement, but it will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Once the warrants become exercisable, the Company may redeem the Public Warrants:

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

•

if, and only if, the reported last sale price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), for any 20 trading days within a 30 trading day period commencing once the warrants become exercisable and ending commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the warrants, each warrant holder will be entitled to exercise its warrant prior to the scheduled redemption date. However, the price of the common stock may fall below the $18.00 redemption trigger price as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.

If the Company calls the warrants for redemption as described above, the management will have the option to require any holder that wishes to exercise its warrant including the holders (other than the original holders) of the Private Placement Warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” the management will consider, among other factors, the Company’s cash position, the number of warrants that are outstanding and the dilutive effect on the stockholders of issuing the maximum number of shares of common stock issuable upon the exercise of the warrants. If the management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. If the management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of common stock to be received upon exercise of the warrants, including the “fair market value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. If the Company calls the warrants for redemption and the management does not take advantage of this option, the holders of the Private Placement Warrants and their permitted transferees would still be entitled to exercise their Private Placement Warrants for cash or on a cashless basis using the same formula described above that other warrant holders would have been required to use had all warrant holders been required to exercise their warrants on a cashless basis.

The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

In addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 10 trading day period starting on the trading day prior the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

Note 9 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Other than as described below and in these financial statements, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statement.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “ADIT EDTECH ACQUISITION CORP.,” “our,” “us” or “we” refer to ADIT EDTECH ACQUISITION CORP. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.

Overview

We are a blank check company incorporated in Delaware and formed for the purpose of effecting an initial business combination with one or more target businesses. We have not identified any specific target business and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any target business regarding an initial business combination with our company. We intend to effectuate our initial business combination using cash from the proceeds of the IPO and the private placement of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock and debt.

The issuance of additional shares of our stock in a business combination:

•

may subordinate the rights of holders of our common stock if preferred stock is issued with rights senior to those afforded our common stock;

•

may subordinate the rights of holders of our common stock if preferred stock is issued with rights senior to those afforded our common stock;

•

could cause a change in control if a substantial number of shares of our common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present management team;

•

may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and

•

may adversely affect prevailing market prices for our common stock and/or warrants.

Similarly, if we issue debt securities, it could result in:

•

default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;

•

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

•

our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;

•

our inability to obtain necessary additional financing if the debt security contains covenants;

•

restricting our ability to obtain such financing while the debt security is outstanding;

•

our inability to pay dividends on our common stock;

•

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes;

•

limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

•

increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;

•

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and

•

other purposes and other disadvantages compared to our competitors who have less debt.

On January 14, 2021, we completed our IPO of 24,000,000 units. Each Unit consists of one share of Common Stock, and one-half of one redeemable Warrant, each whole Warrant entitling the holder thereof to purchase one share of Common Stock at an exercise price of $11.50 per share, subject to adjustment, pursuant to the Company’s registration statements on Form S-1 (File Nos. 333-251641 and 333-252021). The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $240,000,000.

On January 15, 2021, the underwriters exercised their over-allotment option in full, and on January 19, 2021, the underwriters purchased an additional 3,600,000 Units at an offering price of $10.00 per Unit, generating gross proceeds of $36,000,000. Simultaneously with the closing of the sale of additional Units, the Company sold an additional 720,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $720,000. As of January 19, 2021, an aggregate amount of $276,000,000 of the net proceeds from the IPO (including the additional 3,600,000 Units and additional 720,000 Private Placement Warrants) were deposited in the Company’s trust account established in connection with the IPO.

We paid a total of $ 5,520,000 in underwriting discounts and commissions and $636,086 for other costs and expenses related to the IPO.

Results of Operations

Our entire activity since inception up to March 31, 2021 relates to our formation, the Initial Public Offering and, since the closing of the Initial Public Offering, a search for a Business Combination candidate. We will not be generating any operating revenues until the closing and completion of our initial Business Combination, at the earliest.

For the three months ended March 31, 2021, we had net loss of $49,954, which consisted of $90,213 in formation and operating costs, offset by $40,259 in interest earned on marketable securities held in the Trust Account.

Liquidity and Capital Resources

As of March 31, 2021, we had approximately $0.7 million in our operating bank account, and working capital of approximately $0.8 million.

Prior to the completion of the Initial Public Offering, our liquidity needs had been satisfied through a capital contribution from the Sponsor of $25,000, to cover certain offering costs, for the founder shares, and the loan under an unsecured promissory note from the Sponsor of $150,000. Subsequent to the consummation of the Initial Public Offering and Private Placement, our liquidity needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account.

In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, provide us Working Capital Loans. To date, there were no Working Capital Loans.

Based on the foregoing, management believes that we will have sufficient working capital and borrowing capacity to meet our needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Off-Balance Sheet Financing Arrangements

As of March 31, 2021, we did not have any off-balance sheet arrangements. We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or entered into any non-financial assets.

Contractual Obligations

At March 31, 2021, we did not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.

JOBS Act

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company”, we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of the IPO or until we are no longer an “emerging growth company,” whichever is earlier.

Critical Accounting Policies

Management’s discussion and analysis of our results of operations and liquidity and capital resources are based on our unaudited condensed financial information. We describe our significant accounting policies in Note 2 - Significant Accounting Policies, of the Notes to Financial Statements included in this report. Our unaudited condensed financial statements have been prepared in accordance with U.S. GAAP. Certain of our accounting policies require that management apply significant judgments in defining the appropriate assumptions integral to financial estimates. On an ongoing basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with U.S. GAAP. Judgments are based on historical experience, terms of existing contracts, industry trends and information available from outside sources, as appropriate. However, by their nature, judgments are subject to an inherent degree of uncertainty, and, therefore, actual results could differ from our estimates.

We have identified the following as our critical accounting policies:

Common Stock Subject to Possible Redemption

Net Income (Loss) Per Common Share

Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common share outstanding for each of the periods. The warrants are exercisable to purchase 21,070,000 shares of common stock in the aggregate.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

All activity from October 15, 2020 (date of inception) through March 31, 2021 relates to our formation, the preparation for our IPO and the search of targets for our initial business combination. We did not have any financial instruments that were exposed to market risks on March 31, 2021.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31, 2021, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our chief executive officer and chief financial officer have concluded that during the period covered by this report, our disclosure controls and procedures were effective.

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the quarter ended of March 31, 2021 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1.

Legal Proceedings.

From time to time, we are subject to claims in legal proceedings arising in the normal course of our business. We do not believe that we are currently party to any pending legal actions that could reasonably be expected to have a material adverse effect on our business, financial condition, results of operations, or cash flows.

Item 1A.

Risk Factors.

As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.

In October 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration of 5,750,000 shares of Common Stock (the “Founder Shares”). On October 27, 2020, the Sponsor transferred 10,000 Founder Shares to each of the Company’s independent directors and 7,500 Founder Shares to each of the Company’s industry advisors at their original purchase price (the Sponsor, independent directors and industry advisors being defined herein collectively as the “initial stockholders”). On January 11, 2021, the Company effected a stock dividend of 1,150,000 shares with respect to the Common Stock, resulting in the initial stockholders holding an aggregate of 6,900,000 Founder Shares (up to 900,000 of which are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised). On January 19, 2021, the underwriter exercised its over-allotment option in full, hence, the 900,000 Founder Shares are no longer subject to forfeiture since then. Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. Each of our initial shareholders is an accredited investor for purposes of Rule 501 of Regulation D. No underwriting discounts or commissions were paid with respect to such sales.

On January 14, 2021, simultaneously with the consummation of the IPO, we completed a private placement of an aggregate of 6,550,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $6,550,000. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

A total of $240,000,000 of the net proceeds from the IPO and the Private Placement was deposited in a trust account established for the benefit of the Company’s public stockholders.

An aggregate amount of $276,000,000 of the net proceeds from the IPO (including the additional 3,600,000 Units and additional 720,000 Private Placement Warrants) was deposited in the Company’s trust account established in connection with the IPO.

We paid a total of $ 5,520,000 in underwriting discounts and commissions and $636,086 for other costs and expenses related to the IPO.

For a description of the use of the proceeds generated in our initial public offering, see Part I, Item 2 of this Form 10-Q.

Item 3.

Defaults Upon Senior Securities.

None.

Item 4.

Mine Safety Disclosures.

Not Applicable.

Item 5.

Other Information.

Not Applicable.

Item 6.

Exhibits.

Exhibit		Description


31.1*		Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
31.2*		Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
32.1*		Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.
32.2*		Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.
101.INS**		XBRL Instance Document

101.SCH**		XBRL Taxonomy Extension Schema Document

101.CAL**		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF**		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB**		XBRL Taxonomy Extension Label Linkbase Document

101.PRE**		XBRL Taxonomy Extension Presentation Linkbase Document

*	Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		Adit EdTech Acquisition Corp.
Dated: July 1, 2021		/s/ David L. Shrier
		David L. Shrier Chief Executive Officer and Chairman (Principal Executive Officer)

Dated: July 1, 2021		/s/ John J. D’Agostino
		John J. D’Agostino Chief Financial Officer (Principal Financial Officer and Accounting Officer)

EX-31.1 2 adex-ex311_9.htm EX-31.1 adex-ex311_9.htm

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, David L. Shrier, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Adit EdTech Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures, and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 1, 2021
	/s/ David L. Shrier
	Name: David L. Shrier
	Title: Chief Executive Officer

EX-31.2 3 adex-ex312_8.htm EX-31.2 adex-ex312_8.htm

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, John J. D’Agostino, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Adit EdTech Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 1, 2021
	/s/ John J. D’Agostino
	Name: John J. D’Agostino
	Title: Chief Financial Officer

EX-32.1 4 adex-ex321_7.htm EX-32.1 adex-ex321_7.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Adit EdTech Acquisition Corp. (the “Company”) on Form 10-Q for the period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David L. Shrier, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Report and results of operations of the Company for the period covered by the Report.

Date:	July 1, 2021	/s/ David L. Shrier
		Name: David L. Shrier
		Title: Chief Executive Officer

This certification accompanies the Report and shall not be deemed “filed” by the Company with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.

EX-32.2 5 adex-ex322_6.htm EX-32.2 adex-ex322_6.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Adit EdTech Acquisition Corp. (the “Company”) on Form 10-Q for the period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John J. D’Agostino, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

Dated:	July 1, 2021	/s/ John J. D’Agostino
		Name: John J. D’Agostino
		Title: Chief Financial Officer

EX-101.INS 6 adex-20210331.xml XBRL INSTANCE DOCUMENT xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 0001830029 2021-01-01 2021-03-31 0001830029 2021-06-30 0001830029 us-gaap:CapitalUnitsMember 2021-01-01 2021-03-31 0001830029 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001830029 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001830029 2021-03-31 0001830029 2020-12-31 0001830029 us-gaap:CommonStockMember 2020-12-31 0001830029 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001830029 us-gaap:RetainedEarningsMember 2020-12-31 0001830029 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001830029 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001830029 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001830029 us-gaap:CommonStockMember 2021-03-31 0001830029 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001830029 us-gaap:RetainedEarningsMember 2021-03-31 0001830029 us-gaap:IPOMember 2021-01-14 2021-01-14 0001830029 us-gaap:IPOMember 2021-01-14 0001830029 2021-01-14 2021-01-14 0001830029 2021-01-14 0001830029 2021-01-19 2021-01-19 0001830029 srt:MaximumMember 2021-01-19 2021-01-19 0001830029 us-gaap:OverAllotmentOptionMember 2021-01-19 2021-01-19 0001830029 2021-01-19 0001830029 adex:InitialPublicOfferingOverAllotmentAndPrivatePlacementMember 2021-01-19 0001830029 us-gaap:IPOMember 2021-03-31 0001830029 srt:MaximumMember 2021-01-01 2021-03-31 0001830029 adex:FounderSharesMember adex:AditEdTechSponsorLimitedLiabilityCompanyMember 2020-10-15 2020-10-31 0001830029 adex:AditEdTechSponsorLimitedLiabilityCompanyMember adex:PromissoryNoteMember 2021-03-31 0001830029 us-gaap:FairValueMeasurementsRecurringMember adex:USMoneyMarketHeldInTrustAccountMember 2021-03-31 0001830029 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember adex:USMoneyMarketHeldInTrustAccountMember 2021-03-31 0001830029 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2021-03-31 0001830029 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2021-03-31 0001830029 us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001830029 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001830029 adex:PublicWarrantsMember 2021-01-14 2021-01-14 0001830029 adex:PublicWarrantsMember 2021-01-14 0001830029 adex:PublicWarrantsMember 2021-01-01 2021-03-31 0001830029 us-gaap:OverAllotmentOptionMember 2021-01-19 0001830029 adex:FounderSharesMember srt:DirectorMember 2020-10-27 2020-10-27 0001830029 adex:FounderSharesMember adex:IndustryAdvisorsMember 2020-10-27 2020-10-27 0001830029 adex:FounderSharesMember 2021-01-11 2021-01-11 0001830029 adex:FounderSharesMember adex:AdvisorMember srt:MaximumMember 2021-01-11 2021-01-11 0001830029 adex:FounderSharesMember 2021-01-19 2021-01-19 0001830029 adex:PromissoryNoteMember adex:AditEdTechSponsorLimitedLiabilityCompanyMember 2020-10-23 0001830029 adex:PromissoryNoteMember adex:AditEdTechSponsorLimitedLiabilityCompanyMember 2021-01-01 2021-03-31 0001830029 adex:PromissoryNoteMember adex:AditEdTechSponsorLimitedLiabilityCompanyMember 2020-10-23 2020-10-23 0001830029 adex:PromissoryNoteMember adex:AditEdTechSponsorLimitedLiabilityCompanyMember 2020-12-31 0001830029 srt:MaximumMember 2021-03-31 0001830029 adex:AditEdTechSponsorLimitedLiabilityCompanyMember srt:MaximumMember 2021-01-11 2021-01-11 0001830029 us-gaap:MoneyMarketFundsMember 2021-03-31 0001830029 us-gaap:USTreasurySecuritiesMember 2021-03-31 0001830029 srt:MinimumMember 2021-01-01 2021-03-31 0001830029 adex:UnderwritingAgreementMember 2021-01-14 2021-01-14 0001830029 adex:UnderwritingAgreementMember srt:MaximumMember 2021-01-14 2021-01-14 0001830029 adex:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2021-01-19 2021-01-19 0001830029 adex:UnderwritingAgreementMember us-gaap:IPOMember 2021-01-19 2021-01-19 0001830029 adex:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember srt:MaximumMember 2021-01-19 2021-01-19 10-Q false 2021-03-31 2021 Q1 ADIT EDTECH ACQUISITION CORP. 0001830029 Yes Yes --12-31 Non-accelerated Filer 34500000 false true true false Units, each consisting of one share of common stock and one-half of one redeemable warrant Common Stock, par value $0.0001 per share Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share ADEX.U ADEX ADEX.WS NYSE NYSE NYSE 001-39872 DE 85-3477678 1345 Avenue of the Americas 33rd Floor New York NY 646 291-6930 true false

729607

35614

292500

469160

1022107

504774

206404

276040259

277268770

504774

11350

330300

18986

150000 150000

180336

480300

9660000

9840336

480300

262428430

826

690

5049658

24310

-50480

-526

5000004

24474

277268770

504774

26242843

0.0001

1000000

0.0001

100000000

8257157

6900000

8257157

6900000

90213

-90213

40259

-49954

19231241

13815426

0.00

6900000

690

24310

-526

27600000

2760

267451154

267453914

-49954

26242843

2624

262425806

262428430

8257157

826

5049658

-50480

-49954

40259

498904

168983

213

-419921

276000000

-276000000

270480000

7270000

636086

277113914

693993

35614

729607

9660000 227738380 34690050 18773

<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note 2 — Summary of Significant Accounting Policies <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021. <p style="text-align:justify;Background-color:#FFFFFF;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on January 21, 2021 and January 13, 2021, respectively. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Emerging Growth Company <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statement. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2021 and December 31, 2020. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investment Held in Trust Account <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investment held in Trust Account consist of United States Treasury securities. The Company classifies its United States Treasury securities as held-to-maturity in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry the investee operates in. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion is included in the “Trust interest income” line item in the statements of operations. Trust interest income is recognized when earned. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.99%;white-space:nowrap">  </td> <td valign="top" style="width:3.99%;white-space:nowrap"> •</td> <td valign="top"> Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.99%;white-space:nowrap"> <p style="text-align:justify;Background-color:#FFFFFF;margin-top:10pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="top" style="width:3.99%;white-space:nowrap"> •</td> <td valign="top"> <p style="text-align:justify;Background-color:#FFFFFF;margin-top:10pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.99%;white-space:nowrap"> <p style="text-align:justify;Background-color:#FFFFFF;margin-top:10pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="top" style="width:3.99%;white-space:nowrap"> •</td> <td valign="top"> <p style="text-align:justify;Background-color:#FFFFFF;margin-top:10pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</td></tr></table></div> <p style="text-align:justify;Background-color:#FFFFFF;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. <p style="text-align:justify;Background-color:#FFFFFF;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet. The fair values of cash and cash equivalents, prepaid expenses, accrued offering costs and expenses, due to related party, and promissory note to related party are estimated to approximate the carrying values as of March 31, 2021 due to the short maturities of such instruments.   <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following tables present information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2021, and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Quoted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Prices In <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Active <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Markets</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Observable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 1)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 2)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 3)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Money Market held in Trust Account</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">809</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">809</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Treasury Securities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,039,450</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,039,450</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,040,259</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,040,259</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At March 31, 2021 and December 31, 2020, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock Subject to Possible Redemption <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock feature certain redemption rights that is considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Income (Loss) Per Common Share <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common share outstanding for each of the periods. The warrants are exercisable to purchase 21,070,000 shares of common stock in the aggregate.   <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s statement of operations includes a presentation of income (loss) per share for common share subject to possible redemption in a manner similar to the two-class method of income (loss) per common share. Net income per common share, basic and diluted, for redeemable common share is calculated by dividing the interest income earned on the Trust Account, by the weighted average number of redeemable common share outstanding since original issuance. Net loss per common share, basic and diluted, for non-redeemable common share is calculated by dividing the net loss, adjusted for income attributable to redeemable common share, by the weighted average number of non-redeemable common share outstanding for the periods. Non-redeemable common share includes the founder shares as these common shares do not have any redemption features and do not participate in the income earned on the Trust Account.   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Months Ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31, 2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock subject to possible redemption</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator: net income allocable to common stock <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   subject to possible redemption</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortized interest income on marketable securities <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   held in trust</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,278</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: interest available to be withdrawn for payment <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   of taxes</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(38,278</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income allocable to common stock subject to <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   possible redemption</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator: weighted average redeemable common <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   stock redeemable common stock, basic and diluted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,231,241</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net income per share, redeemable <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   common stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-redeemable common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator: net loss minus redeemable net earnings</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,954</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Redeemable net earnings</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-redeemable net loss</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,954</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator: weighted average non-redeemable basic <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   and diluted weighted average shares outstanding, common <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,815,426</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share, common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.00</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> </table></div>   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Offering Costs associated with the Initial Public Offering <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A— “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to stockholders’ equity upon the completion of the IPO. Accordingly, on January 14, 2021, offering costs in the aggregate of $13,836,086 have been charged to stockholders’ equity (consisting of $4,800,000 of underwriting discount, $8,400,000 of deferred underwriting discount, and $636,086 of other offering costs).   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Derivative Financial Instruments   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Stock (“ASC 815-40”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has evaluated both the public and private warrants under ASC 480 and ASC 815-40 and has concluded that it is properly classified as equity instruments.   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the unaudited condensed financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASC 740 prescribes a recognition threshold and a measurement attribute for the unaudited condensed financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Risks and Uncertainties <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management continues to evaluate the impact of the COVID-19 pandemic on the Company’s financial statements and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statement.

<p style="text-align:justify;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note 5 — Related Party Transactions <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Founder Shares <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration of 5,750,000 shares of the Company’s common stock (the “Founder Shares”). On October 27, 2020, the Sponsor transferred 10,000 Founder Shares to each of the Company’s independent directors and 7,500 Founder Shares to each of the Company’s industry advisors at their original purchase price (the Sponsor, independent directors and industry advisors being defined herein collectively as the “initial stockholders”). On January 11, 2021, the Company effected a stock dividend of 1,150,000 shares with respect to the common stock, resulting in the initial stockholders holding an aggregate of 6,900,000 Founder Shares (up to 900,000 of which are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised). As such, the initial stockholders collectively own 20% of the Company’s issued and outstanding shares of common stock after the IPO. On January 19, 2021, the underwriter exercised its over-allotment option in full, hence, the 900,000 Founder Shares are no longer subject to forfeiture since then. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The initial stockholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Due to Related Parties <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2021, one related party paid an aggregate of $18,986 on behalf of the Company to pay for offering and operating costs. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Promissory Note — Related Party <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 23, 2020 the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $150,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) June 30, 2021, (ii) the consummation of the IPO, (iii) the abandonment of the IPO and (iv) an Event of Default as defined in the Promissory Note. As of March 31, 2021 and December 31, 2020, the Company had borrowed $150,000 under the Promissory Note. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Related Party Loans <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order to finance transaction costs in connection with a Business Combination, the Initial Stockholder, the Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $2,000,000 of the notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of March 31, 2021 and December 31, 2020, no such Working Capital Loans were outstanding. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Administrative Service Fee <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company entered into an agreement whereby, commencing on January 11, 2021, the Company has agreed to pay the Sponsor or an affiliate of the Sponsor an amount up to a total of $10,000 per month for office space, utilities, secretarial support and administrative services. Upon completion of the initial Business Combination or liquidation, the Company will cease paying these monthly fees.

<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note 7 — Commitments and Contingencies <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registration Rights <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement signed on January 11, 2021, requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Underwriting Agreement  <p style="text-align:justify;Background-color:#FFFFFF;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The underwriters have a 45-day option beginning January 14, 2021 to purchase up to an additional 3,600,000 units to cover over-allotments, if any, at the IPO price less the underwriting discounts. <p style="text-align:justify;Background-color:#FFFFFF;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 19, 2021, the underwriters purchased an additional 3,600,000 units to exercise its over-allotment option in full. The proceeds of $36,000,000 from the over-allotment was deposited in the Trust Account after deducting the underwriting discounts. <p style="text-align:justify;Background-color:#FFFFFF;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The underwriters were paid a cash underwriting discount of 2.0% of the gross proceeds of the IPO, or $5,520,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of 3.5% of the gross proceeds of the IPO, or $8,400,000 (or up to $9,660,000 if the underwriters’ over-allotment is exercised in full).

<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following tables present information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2021, and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Quoted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Prices In <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Active <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Markets</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Observable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 1)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 2)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 3)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Money Market held in Trust Account</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">809</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">809</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Treasury Securities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,039,450</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,039,450</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,040,259</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,040,259</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s statement of operations includes a presentation of income (loss) per share for common share subject to possible redemption in a manner similar to the two-class method of income (loss) per common share. Net income per common share, basic and diluted, for redeemable common share is calculated by dividing the interest income earned on the Trust Account, by the weighted average number of redeemable common share outstanding since original issuance. Net loss per common share, basic and diluted, for non-redeemable common share is calculated by dividing the net loss, adjusted for income attributable to redeemable common share, by the weighted average number of non-redeemable common share outstanding for the periods. Non-redeemable common share includes the founder shares as these common shares do not have any redemption features and do not participate in the income earned on the Trust Account.   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Months Ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31, 2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock subject to possible redemption</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator: net income allocable to common stock <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   subject to possible redemption</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortized interest income on marketable securities <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   held in trust</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,278</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: interest available to be withdrawn for payment <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   of taxes</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(38,278</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income allocable to common stock subject to <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   possible redemption</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator: weighted average redeemable common <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   stock redeemable common stock, basic and diluted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,231,241</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net income per share, redeemable <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   common stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-redeemable common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator: net loss minus redeemable net earnings</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,954</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Redeemable net earnings</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-redeemable net loss</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,954</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator: weighted average non-redeemable basic <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   and diluted weighted average shares outstanding, common <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,815,426</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share, common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.00</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> </table></div>

<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities on March 31, 2021 are as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value/Amortized <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">as of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31, 2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Money Market</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">809</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">809</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Treasury Securities</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,039,450</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,789</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,045,240</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,040,259</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,789</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,046,049</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

24000000

10.00

240000000

6550000 1.00

6550000

13836086

4800000 8400000 636086 P45D 3600000

3600000

36000000

720000 720000 1.00

720000

10.00

276000000

10.00 5000001 0.15 1.00 2023-01-14 100000

10.00

100000

700000 800000

25000

150000

809

276039450

276040259

250000

21070000

38278 -38278

13836086

4800000 8400000 636086

24000000

10.00

11.50

276000000

11.50

5750000

10000

7500

1150000

6900000

900000 0.20 900000 P1Y

12.00

P20D P30D P150D

150000

The Promissory Note is non-interest bearing and payable on the earlier of (i) June 30, 2021, (ii) the consummation of the IPO, (iii) the abandonment of the IPO and (iv) an Event of Default as defined in the Promissory Note.

2021-06-30

150000

2000000

1.00

0 0

10000

809

276039450

P3M P1Y

809

276039450

276040259

5789

809

276045240

276046049

2021-01-11 The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement signed on January 11, 2021, requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. P45D 3600000

3600000

36000000

0.020

5520000

0.035 8400000 9660000 P30D P5Y 0 0.01 P30D 18.00 P20Y P30Y P3Y 18.00 11.50 9.20 0.60 P10Y 1.15 1.80

EX-101.SCH 7 adex-20210331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Condensed Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Condensed Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Unaudited Condensed Statement of Operations link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Unaudited Condensed Statement of Changes in Stockholder's Equity link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Unaudited Condensed Statement of Changes in Stockholder's Equity (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100060 - Statement - Unaudited Condensed Statement of Cash Flows link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Organization and Business Operations link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Initial Public Offering link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Private Placement link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Related Party Transactions link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Cash and Securities Held in Trust Account link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Stockholder's Equity link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Subsequent Events link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Summary of Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Cash and Securities Held in Trust Account (Tables) link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Organization and Business Operations - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Summary of Significant Accounting Policies - Schedule of Net Income Per Common Share (Details) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Initial Public Offering - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Private Placement- Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Related Party Transactions - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Cash and Securities Held in Trust Account - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Cash and Securities Held in Trust Account - Schedule of Carrying Value, Excluding Gross Unrealized Holding Loss and Fair Value of Held to Maturity Securities (Details) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Stockholder's Equity - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 8 adex-20210331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 adex-20210331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 adex-20210331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Information [Table] Document Information [Table] Class of Stock Statement Class Of Stock [Axis] Class of Stock Class Of Stock [Domain] Units Capital Units [Member] Common Stock Common Stock [Member] Redeemable Warrants Warrant [Member] Document Information [Line Items] Document Information [Line Items] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity Shell Company Entity Shell Company Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Due to related parties promissory notes payable current. Deferred underwriting discount, noncurrent. Statement Of Financial Position [Abstract] Assets Assets [Abstract] Current asset - Cash Cash Prepaid expenses Prepaid Expense Current Deferred offering costs Deferred Offering Costs Total current assets Assets Current Prepaid expenses, non-current Prepaid Expense Noncurrent Cash and securities held in Trust Account Assets Held In Trust Noncurrent Total Assets Assets Liabilities and Stockholders’ Equity Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accrued offering costs and expenses Accounts Payable And Accrued Liabilities Current Due to related party Due To Related Parties Current Promissory note - related party Due To Related Parties Promissory Notes Payable Current Total current liabilities Liabilities Current Deferred underwriting discount Deferred Underwriting Discount Noncurrent Total liabilities Liabilities Commitments Commitments And Contingencies Common Stock subject to possible redemption, 26,242,843 and 0 shares at redemption value, respectively Temporary Equity Aggregate Amount Of Redemption Requirement Stockholders’ Equity: Stockholders Equity [Abstract] Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding Preferred Stock Value Common stock, $0.0001 par value; 100,000,000 shares authorized; 8,257,157 and 6,900,000 shares issued and outstanding (excluding 26,242,843 and 0 shares subject to possible redemption, respectively) Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated deficit Retained Earnings Accumulated Deficit Total Stockholders’ equity Stockholders Equity Total Liabilities and Stockholders’ Equity Liabilities And Stockholders Equity Common stock, shares redemption Temporary Equity Shares Outstanding Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Preferred stock, shares authorized Preferred Stock Shares Authorized Preferred stock, shares issued Preferred Stock Shares Issued Preferred stock, shares outstanding Preferred Stock Shares Outstanding Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Weighted average redeemable common basic and diluted. Income Statement [Abstract] Formation and operating costs Operating Expenses Loss from operations Operating Income Loss Other income Other Nonoperating Income Expense [Abstract] Trust interest income Investment Income Interest Total other income Nonoperating Income Expense Net loss Net Income Loss Basic and diluted weighted average shares outstanding, common stock subject to redemption Weighted Average Redeemable Common Basic And Diluted Basic and diluted net income (loss) per share Earnings Per Share Basic And Diluted Basic and diluted weighted average shares outstanding, common stock Weighted Average Number Of Share Outstanding Basic And Diluted Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Retained Earnings Statement Equity Components [Axis] Equity Component Equity Component [Domain] Additional Paid-in Capital Additional Paid In Capital [Member] Retained Earnings Retained Earnings [Member] Statement [Line Items] Statement [Line Items] Balance Balance, shares Shares Outstanding Sale of Units, net of underwriting discount and offering expenses Stock Issued During Period Value New Issues Sale of Units, net of underwriting discount and offering expenses, shares Stock Issued During Period Shares New Issues Net loss Change in common stock subject to possible redemption Stock Redeemed Or Called During Period Value Change in common stock subject to possible redemption, shares Stock Redeemed Or Called During Period Shares Balance Balance, shares Number of sale units Interest earned on cash and marketable securities held in trust account. Investment held in trust account. Proceeds from initial public offering, net of underwriters’ fees. Payments of offering costs. Deferred underwriting commissions charged to additional paid in capital. Initial value of common stock subject to possible redemption. Change in value of common stock subject to possible redemption. Deferred offering costs paid by sponsor loan. Statement Of Cash Flows [Abstract] Cash flows from Operating Activities: Net Cash Provided By Used In Operating Activities [Abstract] Net loss Profit Loss Adjustments to reconcile net loss to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Interest earned on cash and marketable securities held in Trust Account Interest Earned On Cash And Marketable Securities Held In Trust Account Changes in current assets and current liabilities: Increase Decrease In Operating Capital [Abstract] Prepaid expenses Increase Decrease In Prepaid Expense Accrued offering costs and expenses Increase Decrease In Accrued Liabilities Due to related party Increase Decrease In Due To Related Parties Net cash used in operating activities Net Cash Provided By Used In Operating Activities Cash Flows from Investing Activities: Net Cash Provided By Used In Investing Activities [Abstract] Investment held in Trust Account Investment Held In Trust Account Net cash used in investing activities Net Cash Provided By Used In Investing Activities Cash flows from Financing Activities: Net Cash Provided By Used In Financing Activities [Abstract] Proceeds from Initial Public Offering, net of underwriters’ fees Proceeds From Initial Public Offering Net Of Underwriters Fees Proceeds from private placement Proceeds From Issuance Of Private Placement Payments of offering costs Payments Of Offering Costs Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Net change in cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash, beginning of the period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations Cash, end of the period Supplemental disclosure of noncash investing and financing activities: Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract] Deferred underwriting commissions charged to additional paid in capital Deferred Underwriting Commissions Charged To Additional Paid In Capital Initial value of common stock subject to possible redemption Initial Value Of Common Stock Subject To Possible Redemption Change in value of common stock subject to possible redemption Change In Value Of Common Stock Subject To Possible Redemption Deferred offering costs paid by Sponsor loan Deferred Offering Costs Paid By Sponsor Loan Organization Consolidation And Presentation Of Financial Statements [Abstract] Organization and Business Operations Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Initial public offering. Initial public offering. Initial Public Offering [Abstract] Initial Public Offering Disclosure [Text Block] Initial Public Offering Disclosure [Text Block] Private placement. Private placement. Private Placement [Abstract] Private Placement Private Placement [Text Block] Related Party Transactions [Abstract] Related Party Transactions Related Party Transactions Disclosure [Text Block] Cash and securities held in trust account. Cash and securities held in trust account. Cash And Securities Held In Trust Account [Abstract] Cash and Securities Held in Trust Account Cash And Securities Held In Trust Account [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Stockholders Equity Note [Abstract] Stockholder's Equity Stockholders Equity Note Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Basis of Presentation Basis Of Accounting Policy Policy [Text Block] Emerging growth company. Emerging Growth Company Emerging Growth Company Policy [Text Block] Use of Estimates Use Of Estimates Cash and Cash Equivalents Cash And Cash Equivalents Policy [Text Block] Investment held in trust account. Investment Held in Trust Account Investment Held In Trust Account Policy [Text Block] Fair Value Measurements Fair Value Measurement Policy Policy [Text Block] Concentration of Credit Risk Concentration Risk Credit Risk Common stock subject to possible redemption. Common Stock Subject to Possible Redemption Common Stock Subject To Possible Redemption Policy [Text Block] Net Income (Loss) Per Common Share Earnings Per Share Policy [Text Block] Offering costs associated with initial public offering. Offering Costs Associated with Initial Public Offering Offering Costs Associated With Initial Public Offering Policy [Text Block] Derivative Financial Instruments Derivatives Reporting Of Derivative Activity Income Taxes Income Tax Policy [Text Block] Risks and uncertainties. Risks and Uncertainties Risks And Uncertainties Policy [Text Block] Recent Accounting Pronouncements New Accounting Pronouncements Policy Policy [Text Block] Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Table [Text Block] Schedule of Net Income Per Common Share Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Schedule of Carrying Value, Excluding Gross Unrealized Holding Loss and Fair Value of Held to Maturity Securities Held To Maturity Securities [Text Block] organization and basis of operations. Organization and business operations. Organization And Business Operations [Table] Organization And Business Operations [Table] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] IPO I P O [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Maximum Maximum [Member] Minimum [Member] Minimum [Member] Over-allotment Option Over Allotment Option [Member] Initial public offering, over-allotment and private placement. Initial Public Offering, Over Allotment and Private Placement Initial Public Offering Over Allotment And Private Placement [Member] Founder shares. Founder Shares Founder Shares [Member] Related Party Related Party Transactions By Related Party [Axis] Related Party Related Party [Domain] Adit EdTech sponsor limited liability company. Sponsor Adit Ed Tech Sponsor Limited Liability Company [Member] Debt Instrument Debt Instrument [Axis] Debt Instrument, Name Debt Instrument Name [Domain] Promissory note. Promissory Note Promissory Note [Member] Organization And Basis Of Operations [Line Items] Organization And Basis Of Operations [Line Items] Shares issued price per share Shares Issued Price Per Share Gross proceeds from issuance of initial public offering Proceeds From Issuance Initial Public Offering Sale of private placement warrants. Cost of per private placement warrant. Number of private placement warrants sold Sale Of Private Placement Warrants Sale price per private placement warrant Cost Of Per Private Placement Warrant Underwriting discount Deferred underwriting discount. Other offering costs. Transaction costs Underwriting discount Underwriting Discount Deferred underwriting discount Deferred Underwriting Discount Other offering costs Other Offering Costs Period of underwriters option to purchase units. Underwriters option to purchase additional units. Deferred underwriting fees. Period of underwriters option to purchase units Period Of Underwriters Option To Purchase Units Underwriters option to purchase additional units Underwriters Option To Purchase Additional Units Aggregate gross proceeds from exercise of underwriters over allotment option Proceeds From Issuance Of Common Stock Deferred underwriting fees Deferred Underwriting Fees Net proceeds placed in Trust Account Assets Held In Trust Anticipated stock redemption price per share. Anticipated stock redemption price per share Anticipated Stock Redemption Price Per Share Business combination minimum threshold limit of net intangible assets required. Minimum net intangible assets required for business combination Business Combination Minimum Threshold Limit Of Net Intangible Assets Required Restriction on public share redemption in case of stockholder approval of business combination. Restriction on redeeming shares in case of stockholder approval of business combination Restriction On Public Share Redemption In Case Of Stockholder Approval Of Business Combination Business combination incomplete, percentage of stock redemption. Business combination incomplete, percentage of stock redemption Business Combination Incomplete Percentage Of Stock Redemption Business combination, completion date of acquisition. EX-101.PRE 11 adex-20210331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2021	Jun. 30, 2021
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Registrant Name	ADIT EDTECH ACQUISITION CORP.
Entity Central Index Key	0001830029
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		34,500,000
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity File Number	001-39872
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-3477678
Entity Address, Address Line One	1345 Avenue of the Americas
Entity Address, Address Line Two	33rd Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
City Area Code	646
Local Phone Number	291-6930
Document Quarterly Report	true
Document Transition Report	false
Units
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of common stock and one-half of one redeemable warrant
Trading Symbol	ADEX.U
Security Exchange Name	NYSE
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	ADEX
Security Exchange Name	NYSE
Redeemable Warrants
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share
Trading Symbol	ADEX.WS
Security Exchange Name	NYSE

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Assets
Current asset - Cash	$ 729,607	$ 35,614
Prepaid expenses	292,500
Deferred offering costs		469,160
Total current assets	1,022,107	504,774
Prepaid expenses, non-current	206,404
Cash and securities held in Trust Account	276,040,259
Total Assets	277,268,770	504,774
Current liabilities:
Accrued offering costs and expenses	11,350	330,300
Due to related party	18,986
Promissory note - related party	150,000	150,000
Total current liabilities	180,336	480,300
Deferred underwriting discount	9,660,000
Total liabilities	9,840,336	480,300
Commitments
Common Stock subject to possible redemption, 26,242,843 and 0 shares at redemption value, respectively	262,428,430
Stockholders’ Equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 8,257,157 and 6,900,000 shares issued and outstanding (excluding 26,242,843 and 0 shares subject to possible redemption, respectively)	826	690
Additional paid-in capital	5,049,658	24,310
Accumulated deficit	(50,480)	(526)
Total Stockholders’ equity	5,000,004	24,474
Total Liabilities and Stockholders’ Equity	$ 277,268,770	$ 504,774

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Statement Of Financial Position [Abstract]
Common stock, shares redemption	26,242,843	0
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	8,257,157	6,900,000
Common stock, shares outstanding	8,257,157	6,900,000

XML 15 R4.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Statement of Operations	3 Months Ended
Unaudited Condensed Statement of Operations	Mar. 31, 2021 USD ($) $ / shares shares
Income Statement [Abstract]
Formation and operating costs	$ 90,213
Loss from operations	(90,213)
Other income
Trust interest income	40,259
Total other income	40,259
Net loss	$ (49,954)
Basic and diluted weighted average shares outstanding, common stock subject to redemption \| shares	19,231,241
Basic and diluted net income (loss) per share \| $ / shares	$ 0.00
Basic and diluted weighted average shares outstanding, common stock \| shares	13,815,426

XML 16 R5.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Statement of Changes in Stockholder's Equity - 3 months ended Mar. 31, 2021 - USD ($)	Total	Common Stock	Additional Paid-in Capital	Retained Earnings
Balance at Dec. 31, 2020	$ 24,474	$ 690	$ 24,310	$ (526)
Balance, shares at Dec. 31, 2020		6,900,000
Sale of Units, net of underwriting discount and offering expenses	267,453,914	$ 2,760	267,451,154
Sale of Units, net of underwriting discount and offering expenses, shares		27,600,000
Net loss	(49,954)			(49,954)
Change in common stock subject to possible redemption	(262,428,430)	$ (2,624)	(262,425,806)
Change in common stock subject to possible redemption, shares		(26,242,843)
Balance at Mar. 31, 2021	$ 5,000,004	$ 826	$ 5,049,658	$ (50,480)
Balance, shares at Mar. 31, 2021		8,257,157

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Statement of Changes in Stockholder's Equity (Parenthetical)	3 Months Ended
	Mar. 31, 2021 shares
Common Stock
Number of sale units	27,600,000

XML 18 R7.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Statement of Cash Flows	3 Months Ended
Unaudited Condensed Statement of Cash Flows	Mar. 31, 2021 USD ($)
Cash flows from Operating Activities:
Net loss	$ (49,954)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on cash and marketable securities held in Trust Account	(40,259)
Changes in current assets and current liabilities:
Prepaid expenses	(498,904)
Accrued offering costs and expenses	168,983
Due to related party	213
Net cash used in operating activities	(419,921)
Cash Flows from Investing Activities:
Investment held in Trust Account	(276,000,000)
Net cash used in investing activities	(276,000,000)
Cash flows from Financing Activities:
Proceeds from Initial Public Offering, net of underwriters’ fees	270,480,000
Proceeds from private placement	7,270,000
Payments of offering costs	(636,086)
Net cash provided by financing activities	277,113,914
Net change in cash	693,993
Cash, beginning of the period	35,614
Cash, end of the period	729,607
Supplemental disclosure of noncash investing and financing activities:
Deferred underwriting commissions charged to additional paid in capital	9,660,000
Initial value of common stock subject to possible redemption	227,738,380
Change in value of common stock subject to possible redemption	34,690,050
Deferred offering costs paid by Sponsor loan	$ 18,773

XML 19 R8.htm IDEA: XBRL DOCUMENT

Organization and Business Operations

3 Months Ended

Mar. 31, 2021

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Organization and Business Operations

Note 1 — Organization and Business Operations

Organization and General

The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

The Company has selected December 31 as its fiscal year end.

The Company’s sponsor is Adit EdTech Sponsor, LLC, a Delaware limited liability company (the “Sponsor”).

Financing

Transaction costs amounted to $13,836,086 consisting of $4,800,000 of underwriting discount, $8,400,000 deferred underwriting discount, and $636,086 of other offering costs.

Trust Account

Initial Business Combination

Liquidity and Capital Resources

As of March 31, 2021, the Company had approximately $0.7 million in its operating bank account, and working capital of approximately $0.8 million.

XML 20 R9.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021.

Emerging Growth Company

Use of Estimates

Cash and Cash Equivalents

Investment Held in Trust Account

Fair Value Measurements

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

	March 31,		Quoted Prices In Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2021		(Level 1)		(Level 2)		(Level 3)
Assets:
U.S. Money Market held in Trust Account	$	809	$	809	$	—	$	—
U.S. Treasury Securities		276,039,450		276,039,450		—		—
	$	276,040,259	$	276,040,259	$	—	$	—

Concentration of Credit Risk

Common Stock Subject to Possible Redemption

Net Income (Loss) Per Common Share

	For the Three Months Ended March 31, 2021
Common stock subject to possible redemption
Numerator: net income allocable to common stock subject to possible redemption
Amortized interest income on marketable securities held in trust	$	38,278
Less: interest available to be withdrawn for payment of taxes		(38,278	)
Net income allocable to common stock subject to possible redemption	$	—
Denominator: weighted average redeemable common stock redeemable common stock, basic and diluted		19,231,241
Basic and diluted net income per share, redeemable common stock	$	—
Non-redeemable common stock
Numerator: net loss minus redeemable net earnings
Net loss	$	(49,954	)
Redeemable net earnings		—
Non-redeemable net loss	$	(49,954	)
Denominator: weighted average non-redeemable basic and diluted weighted average shares outstanding, common stock		13,815,426
Basic and diluted net loss per share, common stock	$	(0.00	)

Offering Costs associated with the Initial Public Offering

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A— “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to stockholders’ equity upon the completion of the IPO. Accordingly, on January 14, 2021, offering costs in the aggregate of $13,836,086 have been charged to stockholders’ equity (consisting of $4,800,000 of underwriting discount, $8,400,000 of deferred underwriting discount, and $636,086 of other offering costs).

Derivative Financial Instruments

The Company has evaluated both the public and private warrants under ASC 480 and ASC 815-40 and has concluded that it is properly classified as equity instruments.

Income Taxes

Risks and Uncertainties

Recent Accounting Pronouncements

XML 21 R10.htm IDEA: XBRL DOCUMENT

Initial Public Offering

3 Months Ended

Mar. 31, 2021

Initial Public Offering [Abstract]

Initial Public Offering Disclosure [Text Block]

Note 3 — Initial Public Offering

On January 19, 2021, the Underwriters exercised the over-allotment option in full to purchase 3,600,000 Units.

Following the closing of the IPO on January 14, 2021 and the underwriters’ full exercise of over-allotment option on January 19, 2021, $276,000,000 was held in the Trust Account.

XML 22 R11.htm IDEA: XBRL DOCUMENT

Private Placement

3 Months Ended

Mar. 31, 2021

Private Placement [Abstract]

Private Placement

Note 4 — Private Placement

XML 23 R12.htm IDEA: XBRL DOCUMENT

Related Party Transactions

3 Months Ended

Mar. 31, 2021

Related Party Transactions

Note 5 — Related Party Transactions

Founder Shares

Due to Related Parties

As of March 31, 2021, one related party paid an aggregate of $18,986 on behalf of the Company to pay for offering and operating costs.

Promissory Note — Related Party

Related Party Loans

Administrative Service Fee

XML 24 R13.htm IDEA: XBRL DOCUMENT

Cash and Securities Held in Trust Account

3 Months Ended

Mar. 31, 2021

Cash And Securities Held In Trust Account [Abstract]

Cash and Securities Held in Trust Account

Note 6 — Cash and Securities Held in Trust Account

The carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities on March 31, 2021 are as follows:

	Carrying Value/Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value as of March 31, 2021
U.S. Money Market	$	809	$	—	$	—	$	809
U.S. Treasury Securities		276,039,450		—		5,789		276,045,240
	$	276,040,259	$	—	$	5,789	$	276,046,049

XML 25 R14.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Mar. 31, 2021

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 7 — Commitments and Contingencies

Registration Rights

Underwriting Agreement

The underwriters have a 45-day option beginning January 14, 2021 to purchase up to an additional 3,600,000 units to cover over-allotments, if any, at the IPO price less the underwriting discounts.

XML 26 R15.htm IDEA: XBRL DOCUMENT

Stockholder's Equity

3 Months Ended

Mar. 31, 2021

Stockholders Equity Note [Abstract]

Stockholder's Equity

Note 8 — Stockholders’ Equity

Once the warrants become exercisable, the Company may redeem the Public Warrants:

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

•

XML 27 R16.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Mar. 31, 2021

Subsequent Events [Abstract]

Subsequent Events

Note 9 — Subsequent Events

XML 28 R17.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Basis of Presentation

Emerging Growth Company

Use of Estimates

Cash and Cash Equivalents

Investment Held in Trust Account

Fair Value Measurements

•

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•

	March 31,		Quoted Prices In Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2021		(Level 1)		(Level 2)		(Level 3)
Assets:
U.S. Money Market held in Trust Account	$	809	$	809	$	—	$	—
U.S. Treasury Securities		276,039,450		276,039,450		—		—
	$	276,040,259	$	276,040,259	$	—	$	—

Concentration of Credit Risk

Common Stock Subject to Possible Redemption

Net Income (Loss) Per Common Share

	For the Three Months Ended March 31, 2021
Common stock subject to possible redemption
Numerator: net income allocable to common stock subject to possible redemption
Amortized interest income on marketable securities held in trust	$	38,278
Less: interest available to be withdrawn for payment of taxes		(38,278	)
Net income allocable to common stock subject to possible redemption	$	—
Denominator: weighted average redeemable common stock redeemable common stock, basic and diluted		19,231,241
Basic and diluted net income per share, redeemable common stock	$	—
Non-redeemable common stock
Numerator: net loss minus redeemable net earnings
Net loss	$	(49,954	)
Redeemable net earnings		—
Non-redeemable net loss	$	(49,954	)
Denominator: weighted average non-redeemable basic and diluted weighted average shares outstanding, common stock		13,815,426
Basic and diluted net loss per share, common stock	$	(0.00	)

Offering Costs Associated with Initial Public Offering

Offering Costs associated with the Initial Public Offering

Derivative Financial Instruments

The Company has evaluated both the public and private warrants under ASC 480 and ASC 815-40 and has concluded that it is properly classified as equity instruments.

Income Taxes

Risks and Uncertainties

Recent Accounting Pronouncements

XML 29 R18.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis

	March 31,		Quoted Prices In Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2021		(Level 1)		(Level 2)		(Level 3)
Assets:
U.S. Money Market held in Trust Account	$	809	$	809	$	—	$	—
U.S. Treasury Securities		276,039,450		276,039,450		—		—
	$	276,040,259	$	276,040,259	$	—	$	—

Schedule of Net Income Per Common Share

	For the Three Months Ended March 31, 2021
Common stock subject to possible redemption
Numerator: net income allocable to common stock subject to possible redemption
Amortized interest income on marketable securities held in trust	$	38,278
Less: interest available to be withdrawn for payment of taxes		(38,278	)
Net income allocable to common stock subject to possible redemption	$	—
Denominator: weighted average redeemable common stock redeemable common stock, basic and diluted		19,231,241
Basic and diluted net income per share, redeemable common stock	$	—
Non-redeemable common stock
Numerator: net loss minus redeemable net earnings
Net loss	$	(49,954	)
Redeemable net earnings		—
Non-redeemable net loss	$	(49,954	)
Denominator: weighted average non-redeemable basic and diluted weighted average shares outstanding, common stock		13,815,426
Basic and diluted net loss per share, common stock	$	(0.00	)

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details

XML 30 R19.htm IDEA: XBRL DOCUMENT

Cash and Securities Held in Trust Account (Tables)

3 Months Ended

Mar. 31, 2021

Cash And Securities Held In Trust Account [Abstract]

Schedule of Carrying Value, Excluding Gross Unrealized Holding Loss and Fair Value of Held to Maturity Securities

The carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities on March 31, 2021 are as follows:

	Carrying Value/Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value as of March 31, 2021
U.S. Money Market	$	809	$	—	$	—	$	809
U.S. Treasury Securities		276,039,450		—		5,789		276,045,240
	$	276,040,259	$	—	$	5,789	$	276,046,049

XML 31 R20.htm IDEA: XBRL DOCUMENT

Organization and Business Operations - Additional Information (Details) - USD ($)			1 Months Ended	3 Months Ended
	Jan. 19, 2021	Jan. 14, 2021	Oct. 31, 2020	Mar. 31, 2021	Dec. 31, 2020
Organization And Basis Of Operations [Line Items]
Number of private placement warrants sold	720,000	6,550,000
Sale price per private placement warrant	$ 1.00	$ 1.00
Proceeds from private placement	$ 720,000	$ 6,550,000		$ 7,270,000
Transaction costs		13,836,086			$ 469,160
Underwriting discount		4,800,000
Deferred underwriting discount		8,400,000
Other offering costs		$ 636,086
Period of underwriters option to purchase units	45 days
Deferred underwriting fees	$ 720,000
Net proceeds placed in Trust Account	$ 276,000,000
Anticipated stock redemption price per share				$ 10.00
Minimum net intangible assets required for business combination				$ 5,000,001
Restriction on redeeming shares in case of stockholder approval of business combination				15.00%
Business combination incomplete, percentage of stock redemption				100.00%
Business combination, completion date of acquisition				Jan. 14, 2023
Business combination incomplete, maximum dissolution expenses to be paid				$ 100,000
Price per Public Share reduction to amount held in Trust Account				$ 10.00
Operating bank account balance				$ 700,000
Working capital				800,000
Sponsor \| Promissory Note
Organization And Basis Of Operations [Line Items]
Promissory note - related party				150,000	$ 150,000
Founder Shares \| Sponsor
Organization And Basis Of Operations [Line Items]
Related party offering costs			$ 25,000
Maximum
Organization And Basis Of Operations [Line Items]
Underwriters option to purchase additional units	3,600,000
Guarantor obligations, liquidation proceeds amount				$ 100,000
IPO
Organization And Basis Of Operations [Line Items]
Sale of Units, net of underwriting discount and offering expenses, shares		24,000,000
Shares issued price per share		$ 10.00		$ 10.00
Gross proceeds from issuance of initial public offering		$ 240,000,000
Transaction costs		13,836,086
Underwriting discount		4,800,000
Deferred underwriting discount		8,400,000
Other offering costs		$ 636,086
Over-allotment Option
Organization And Basis Of Operations [Line Items]
Sale of Units, net of underwriting discount and offering expenses, shares	3,600,000
Aggregate gross proceeds from exercise of underwriters over allotment option	$ 36,000,000
Net proceeds placed in Trust Account	$ 276,000,000
Initial Public Offering, Over Allotment and Private Placement
Organization And Basis Of Operations [Line Items]
Shares issued price per share	$ 10.00

XML 32 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Recurring Basis	Mar. 31, 2021 USD ($)
Assets:
Assets, fair value	$ 276,040,259
U.S. Money Market held in Trust Account
Assets:
Assets, fair value	809
U.S. Treasury Securities
Assets:
Assets, fair value	276,039,450
Quoted Prices in Active Markets (Level 1)
Assets:
Assets, fair value	276,040,259
Quoted Prices in Active Markets (Level 1) \| U.S. Money Market held in Trust Account
Assets:
Assets, fair value	809
Quoted Prices in Active Markets (Level 1) \| U.S. Treasury Securities
Assets:
Assets, fair value	$ 276,039,450

XML 33 R22.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)		3 Months Ended
	Jan. 14, 2021	Mar. 31, 2021	Dec. 31, 2020
Summary Of Significant Accounting Policies [Line Items]
Federal deposit insurance coverage		$ 250,000
Warrants exercisable to purchase		21,070,000
Deferred offering costs	$ 13,836,086		$ 469,160
Underwriting discount	4,800,000
Deferred underwriting discount	8,400,000
Other offering costs	636,086
IPO
Summary Of Significant Accounting Policies [Line Items]
Deferred offering costs	13,836,086
Underwriting discount	4,800,000
Deferred underwriting discount	8,400,000
Other offering costs	$ 636,086

XML 34 R23.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Net Income Per Common Share (Details)	3 Months Ended
	Mar. 31, 2021 USD ($) $ / shares shares
Net Income Loss [Abstract]
Amortized interest income on marketable securities held in trust	$ 38,278
Less: interest available to be withdrawn for payment of taxes	(38,278)
Net income allocable to common stock subject to possible redemption	$ 34,690,050
Denominator: weighted average redeemable common stock redeemable common stock, basic and diluted \| shares	19,231,241
Net loss	$ (49,954)
Non-redeemable net loss	$ (49,954)
Denominator: weighted average non-redeemable basic and diluted weighted average shares outstanding, common stock \| shares	13,815,426
Basic and diluted net loss per share, common stock \| $ / shares	$ 0.00

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

XML 35 R24.htm IDEA: XBRL DOCUMENT

Initial Public Offering - Additional Information (Details) - USD ($)			3 Months Ended
	Jan. 19, 2021	Jan. 14, 2021	Mar. 31, 2021
Initial Public Offering [Line Items]
Common stock price per share			$ 12.00
Amount held in trust account	$ 276,000,000
Public Warrant
Initial Public Offering [Line Items]
Number of sale units		24,000,000
Purchase price per unit		$ 10.00
Common stock price per share		$ 11.50
Description of conversion feature			Pursuant to the IPO on January 14, 2021, the Company sold 24,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of common stock and one half of one warrant to purchase one share of common stock (“Public Warrant”).
IPO
Initial Public Offering [Line Items]
Number of sale units		24,000,000
Purchase price per unit		$ 10.00	$ 10.00
Common stock price per share		$ 11.50
Underwriters Exercise of Over-Allotment Option
Initial Public Offering [Line Items]
Number of sale units	3,600,000
Amount held in trust account	$ 276,000,000

XML 36 R25.htm IDEA: XBRL DOCUMENT

Private Placement- Additional Information (Details) - USD ($)			3 Months Ended
	Jan. 19, 2021	Jan. 14, 2021	Mar. 31, 2021
Private Placement [Line Items]
Sale of private placement warrants	720,000	6,550,000
Cost of per private placement warrant	$ 1.00	$ 1.00
Proceeds from issuance of private placement	$ 720,000	$ 6,550,000	$ 7,270,000
Common stock price per share			$ 12.00
Over-allotment Option
Private Placement [Line Items]
Underwriters exercise of over-allotment option	3,600,000
IPO
Private Placement [Line Items]
Underwriters exercise of over-allotment option		24,000,000
Common stock price per share		$ 11.50

XML 37 R26.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Additional Information (Details) - USD ($)					1 Months Ended	3 Months Ended
	Jan. 19, 2021	Jan. 11, 2021	Oct. 27, 2020	Oct. 23, 2020	Oct. 31, 2020	Mar. 31, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Share holding period upon closing of business combination						1 year
Common stock price per share						$ 12.00
Number of trading days						20 days
Number of consecutive trading days						30 days
Minimum share holding period upon closing of business combination						150 days
Related party transaction for offering and operating costs						$ 18,986
Exercise price per warrant						$ 1.00
Working capital loans outstanding						$ 0	$ 0
Maximum
Related Party Transaction [Line Items]
Warrants issuable on notes conversion upon completion of business combination						$ 2,000,000
Sponsor \| Promissory Note
Related Party Transaction [Line Items]
Aggregate principal amount				$ 150,000
Debt instrument, payment terms						The Promissory Note is non-interest bearing and payable on the earlier of (i) June 30, 2021, (ii) the consummation of the IPO, (iii) the abandonment of the IPO and (iv) an Event of Default as defined in the Promissory Note.
Debt instrument, maturity date				Jun. 30, 2021
Promissory note - related party						$ 150,000	$ 150,000
Sponsor \| Maximum
Related Party Transaction [Line Items]
Related party transaction, administrative service fee per month		$ 10,000
Founder Shares
Related Party Transaction [Line Items]
Issuance of common stock, shares		6,900,000
Common stock dividend, shares		1,150,000
Ownership percentage of initial stockholders		20.00%
Common stock, shares not subject to forfeiture	900,000
Founder Shares \| Sponsor
Related Party Transaction [Line Items]
Related party offering costs					$ 25,000
Issuance of common stock, shares					5,750,000
Founder Shares \| Independent Directors
Related Party Transaction [Line Items]
Issuance of common stock, shares			10,000
Founder Shares \| Industry Advisors
Related Party Transaction [Line Items]
Issuance of common stock, shares			7,500
Founder Shares \| Advisor \| Maximum
Related Party Transaction [Line Items]
Common stock, shares subject to forfeiture		900,000

XML 38 R27.htm IDEA: XBRL DOCUMENT

Cash and Securities Held in Trust Account - Additional Information (Details)	3 Months Ended
	Mar. 31, 2021 USD ($)
Cash And Securities Held In Trust Account [Line Items]
Cash and securities held in Trust Account	$ 276,040,259
Minimum [Member]
Cash And Securities Held In Trust Account [Line Items]
Short term investments original maturity term	3 months
Maximum
Cash And Securities Held In Trust Account [Line Items]
Short term investments original maturity term	1 year
U.S. Money Market
Cash And Securities Held In Trust Account [Line Items]
Cash and securities held in Trust Account	$ 809
U.S. Treasury Securities
Cash And Securities Held In Trust Account [Line Items]
Cash and securities held in Trust Account	$ 276,039,450

XML 39 R28.htm IDEA: XBRL DOCUMENT

Cash and Securities Held in Trust Account - Schedule of Carrying Value, Excluding Gross Unrealized Holding Loss and Fair Value of Held to Maturity Securities (Details)	Mar. 31, 2021 USD ($)
Schedule Of Held To Maturity Securities [Line Items]
Investment Securities Held-to-Maturity, Carrying Value/Amortized Cost	$ 276,040,259
Investment Securities Held-to-Maturity, Gross Unrealized Losses	5,789
Investment Securities Held-to-Maturity, Fair Value	276,046,049
U.S. Money Market
Schedule Of Held To Maturity Securities [Line Items]
Investment Securities Held-to-Maturity, Carrying Value/Amortized Cost	809
Investment Securities Held-to-Maturity, Fair Value	809
U.S. Treasury Securities
Schedule Of Held To Maturity Securities [Line Items]
Investment Securities Held-to-Maturity, Carrying Value/Amortized Cost	276,039,450
Investment Securities Held-to-Maturity, Gross Unrealized Losses	5,789
Investment Securities Held-to-Maturity, Fair Value	$ 276,045,240

XML 40 R29.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Additional Information (Details) - USD ($)			3 Months Ended
	Jan. 19, 2021	Jan. 14, 2021	Mar. 31, 2021
Commitments And Contingencies [Line Items]
Registration rights agreement date			Jan. 11, 2021
Registration rights agreement term			The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement signed on January 11, 2021, requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Period of underwriters option to purchase units	45 days
Deferred fee	$ 720,000
Over-allotment Option
Commitments And Contingencies [Line Items]
Underwriters exercise of over-allotment option	3,600,000
Gross proceeds from underwriters over-allotment option	$ 36,000,000
IPO
Commitments And Contingencies [Line Items]
Underwriters exercise of over-allotment option		24,000,000
Gross proceeds from issuance of initial public offering		$ 240,000,000
Maximum
Commitments And Contingencies [Line Items]
Underwriters option to purchase additional units	3,600,000
Underwriting Agreement
Commitments And Contingencies [Line Items]
Period of underwriters option to purchase units		45 days
Underwriting Agreement \| Over-allotment Option
Commitments And Contingencies [Line Items]
Underwriters exercise of over-allotment option	3,600,000
Gross proceeds from underwriters over-allotment option	$ 36,000,000
Underwriting Agreement \| IPO
Commitments And Contingencies [Line Items]
Underwriting discount paid in cash on gross proceeds of IPO percentage	2.00%
Gross proceeds from issuance of initial public offering	$ 5,520,000
Deferred fee on gross proceeds of IPO percentage	3.50%
Deferred fee	$ 8,400,000
Underwriting Agreement \| Maximum
Commitments And Contingencies [Line Items]
Underwriters option to purchase additional units		3,600,000
Underwriting Agreement \| Maximum \| Over-allotment Option
Commitments And Contingencies [Line Items]
Deferred fee	$ 9,660,000

XML 41 R30.htm IDEA: XBRL DOCUMENT

Stockholder's Equity - Additional Information (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Stockholders Equity Note [Abstract]
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	100,000,000	100,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares issued	8,257,157	6,900,000
Common stock, shares outstanding	8,257,157	6,900,000
Common stock, shares redemption	26,242,843	0
Warrants exercisable period after completion of business combination	30 days
Warrant expiration period after completion of business combination or earlier upon redemption or liquidation.	5 years
Warrants exercisable	0
Redemption price per warrant	$ 0.01
Minimum period of prior written notice of redemption of warrants	30 days
Minimum price per share required for redemption of warrants	$ 18.00
Warrants redemption covenant, threshold trading days	20 years
Warrants redemption covenant threshold consecutive trading days	30 years
Number of business days before sending notice of redemption period	3 years
Redemption triggering price of warrants	$ 18.00
Warrants redemption exercise price per share	11.50
Maximum effective issue price to closing of business combination	$ 9.20
Minimum percentage of total equity proceeds from issuances	60.00%
Number of trading days prior on consummates business combination	10 years
Percentage of exercise price of warrants adjusted equal to higher of market value and newly issued price	115.00%
Percentage of warrant redemption trigger price adjusted equal to higher of market value and newly issued price.	180.00%

EXCEL 42 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 44 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 58 257 1 false 25 0 false 4 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.adit.com/20210331/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Balance Sheets Sheet http://www.adit.com/20210331/taxonomy/role/StatementCondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.adit.com/20210331/taxonomy/role/StatementCondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Unaudited Condensed Statement of Operations Sheet http://www.adit.com/20210331/taxonomy/role/StatementUnauditedCondensedStatementOfOperations Unaudited Condensed Statement of Operations Statements 4 false false R5.htm 100040 - Statement - Unaudited Condensed Statement of Changes in Stockholder's Equity Sheet http://www.adit.com/20210331/taxonomy/role/StatementUnauditedCondensedStatementOfChangesInStockholderSEquity Unaudited Condensed Statement of Changes in Stockholder's Equity Statements 5 false false R6.htm 100050 - Statement - Unaudited Condensed Statement of Changes in Stockholder's Equity (Parenthetical) Sheet http://www.adit.com/20210331/taxonomy/role/StatementUnauditedCondensedStatementOfChangesInStockholderSEquityParenthetical Unaudited Condensed Statement of Changes in Stockholder's Equity (Parenthetical) Statements 6 false false R7.htm 100060 - Statement - Unaudited Condensed Statement of Cash Flows Sheet http://www.adit.com/20210331/taxonomy/role/StatementUnauditedCondensedStatementOfCashFlows Unaudited Condensed Statement of Cash Flows Statements 7 false false R8.htm 100070 - Disclosure - Organization and Business Operations Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureOrganizationAndBusinessOperations Organization and Business Operations Notes 8 false false R9.htm 100080 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 100090 - Disclosure - Initial Public Offering Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureInitialPublicOffering Initial Public Offering Notes 10 false false R11.htm 100100 - Disclosure - Private Placement Sheet http://www.adit.com/20210331/taxonomy/role/DisclosurePrivatePlacement Private Placement Notes 11 false false R12.htm 100110 - Disclosure - Related Party Transactions Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 100120 - Disclosure - Cash and Securities Held in Trust Account Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureCashAndSecuritiesHeldInTrustAccount Cash and Securities Held in Trust Account Notes 13 false false R14.htm 100130 - Disclosure - Commitments and Contingencies Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 100140 - Disclosure - Stockholder's Equity Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureStockholderSEquity Stockholder's Equity Notes 15 false false R16.htm 100150 - Disclosure - Subsequent Events Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 16 false false R17.htm 100160 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.adit.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 17 false false R18.htm 100170 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.adit.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 18 false false R19.htm 100180 - Disclosure - Cash and Securities Held in Trust Account (Tables) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureCashAndSecuritiesHeldInTrustAccountTables Cash and Securities Held in Trust Account (Tables) Tables http://www.adit.com/20210331/taxonomy/role/DisclosureCashAndSecuritiesHeldInTrustAccount 19 false false R20.htm 100190 - Disclosure - Organization and Business Operations - Additional Information (Details) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureOrganizationAndBusinessOperationsAdditionalInformationDetails Organization and Business Operations - Additional Information (Details) Details 20 false false R21.htm 100200 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Summary of Significant Accounting Policies - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 21 false false R22.htm 100210 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 22 false false R23.htm 100220 - Disclosure - Summary of Significant Accounting Policies - Schedule of Net Income Per Common Share (Details) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfNetIncomePerCommonShareDetails Summary of Significant Accounting Policies - Schedule of Net Income Per Common Share (Details) Details 23 false false R24.htm 100230 - Disclosure - Initial Public Offering - Additional Information (Details) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureInitialPublicOfferingAdditionalInformationDetails Initial Public Offering - Additional Information (Details) Details 24 false false R25.htm 100240 - Disclosure - Private Placement- Additional Information (Details) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosurePrivatePlacementAdditionalInformationDetails Private Placement- Additional Information (Details) Details 25 false false R26.htm 100250 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 26 false false R27.htm 100260 - Disclosure - Cash and Securities Held in Trust Account - Additional Information (Details) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureCashAndSecuritiesHeldInTrustAccountAdditionalInformationDetails Cash and Securities Held in Trust Account - Additional Information (Details) Details 27 false false R28.htm 100270 - Disclosure - Cash and Securities Held in Trust Account - Schedule of Carrying Value, Excluding Gross Unrealized Holding Loss and Fair Value of Held to Maturity Securities (Details) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureCashAndSecuritiesHeldInTrustAccountScheduleOfCarryingValueExcludingGrossUnrealizedHoldingLossAndFairValueOfHeldToMaturitySecuritiesDetails Cash and Securities Held in Trust Account - Schedule of Carrying Value, Excluding Gross Unrealized Holding Loss and Fair Value of Held to Maturity Securities (Details) Details 28 false false R29.htm 100280 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 29 false false R30.htm 100290 - Disclosure - Stockholder's Equity - Additional Information (Details) Sheet http://www.adit.com/20210331/taxonomy/role/DisclosureStockholderSEquityAdditionalInformationDetails Stockholder's Equity - Additional Information (Details) Details 30 false false All Reports Book All Reports adex-20210331.xml adex-20210331.xsd adex-20210331_cal.xml adex-20210331_def.xml adex-20210331_lab.xml adex-20210331_pre.xml http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true ZIP 47 0001564590-21-035566-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-21-035566-xbrl.zip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end